FDA — authorised 12 August 2013
- Application: NDA204790
- Marketing authorisation holder: VIIV HLTHCARE
- Status: supplemented
🇺🇸 Tivicay in United States
FDA authorised Tivicay on 12 August 2013
Marketing authorisations
FDA — authorised 12 June 2020
- Application: NDA213983
- Marketing authorisation holder: VIIV HLTHCARE
- Status: approved
FDA
- Status: approved
Other Immunology approved in United States
Frequently asked questions
Is Tivicay approved in United States?
Yes. FDA authorised it on 12 August 2013; FDA authorised it on 12 June 2020; FDA has authorised it.
Who is the marketing authorisation holder for Tivicay in United States?
VIIV HLTHCARE holds the US marketing authorisation.